MRI-Guided Prostate Interventions.
暂无分享,去创建一个
[1] B. Reid,et al. Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening , 2016, Journal of cellular physiology.
[2] D. Margolis,et al. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. , 2016, The Journal of urology.
[3] Yousef Mazaheri,et al. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. , 2016, AJR. American journal of roentgenology.
[4] Stephanie L. Lee,et al. ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[5] Walter Kucharczyk,et al. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes. , 2015, AJR. American journal of roentgenology.
[6] E. Schaeffer,et al. Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience , 2015, The Prostate.
[7] J. Barentsz,et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.
[8] M. Cooperberg,et al. Updated trends in imaging use in men diagnosed with prostate cancer , 2014, Prostate Cancer and Prostatic Disease.
[9] Hessel Wijkstra,et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.
[10] J. Felmlee,et al. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. , 2013, Urology.
[11] J. Bomers,et al. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. , 2013, Radiology.
[12] P. Choyke,et al. Magnetic resonance imaging (MRI)‐guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI‐based moulds , 2013, BJU international.
[13] Yipeng Hu,et al. Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system , 2013, BJU international.
[14] A. Oto,et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. , 2013, Radiology.
[15] Robert A Weersink,et al. Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[16] W. Travis,et al. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] M. Cooperberg,et al. Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis , 2013, BJU international.
[18] Carlo Catalano,et al. Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. , 2013, European urology.
[19] Matthias Günther,et al. High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. , 2012, Zeitschrift fur medizinische Physik.
[20] Rajiv Chopra,et al. MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. , 2012, Radiology.
[21] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[22] W. Linehan,et al. Image guidance in the focal treatment of prostate cancer , 2012, Current opinion in urology.
[23] Osamu Ukimura,et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. , 2012, European urology.
[24] J. Ward,et al. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry , 2012, BJU international.
[25] A. Ouzzane,et al. Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future , 2012, Advances in urology.
[26] A. Gangi,et al. Percutaneous MR-guided cryoablation of prostate cancer: initial experience , 2012, European Radiology.
[27] L. Norton,et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. , 2012, Cancer research.
[28] F. Grizzi,et al. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling , 2011, BJU international.
[29] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[30] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[31] H. Hricak,et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.
[32] H. Ahmed,et al. Focal therapy for localized prostate cancer: a phase I/II trial. , 2011, The Journal of urology.
[33] M. Bronskill,et al. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. , 2010, Urology.
[34] Nathan Lawrentschuk,et al. Focal therapy in prostate cancer: modalities, findings and future considerations , 2010, Nature Reviews Urology.
[35] R. Passariello,et al. Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA) , 2010, La radiologia medica.
[36] C. Lallas,et al. Hormone therapy in the management of prostate cancer: evidence-based approaches , 2010, Therapeutic advances in urology.
[37] T. H. van der Kwast,et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.
[38] Matthew R Cooperberg,et al. Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] David C. Miller,et al. Primary and salvage cryotherapy for prostate cancer. , 2010, The Urologic clinics of North America.
[40] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[41] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.
[42] Hashim Uddin Ahmed,et al. The index lesion and the origin of prostate cancer. , 2009, The New England journal of medicine.
[43] David P. Smith,et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study , 2009, BMJ : British Medical Journal.
[44] Yujun Guo,et al. Image Registration Accuracy of a 3‐Dimensional Transrectal Ultrasound–Guided Prostate Biopsy System , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[45] A Fenster,et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. , 2009, The Journal of urology.
[46] Andrew J Vickers,et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Jun Luo,et al. Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.
[48] Rajiv Chopra,et al. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback , 2009, Physics in medicine and biology.
[49] L. Holmberg,et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. , 2008, Journal of the National Cancer Institute.
[50] I. Tuerk,et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. , 2008, European urology.
[51] John T. Wei,et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.
[52] Kim Butts Pauly,et al. Echo combination to reduce proton resonance frequency (PRF) thermometry errors from fat , 2008, Journal of magnetic resonance imaging : JMRI.
[53] P. Scardino,et al. 1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens , 2006 .
[54] Thomas Kahn,et al. Interventional and intraoperative MR: review and update of techniques and clinical experience , 2004, European Radiology.
[55] Jacob Sosna,et al. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.
[56] Ashok Gowda,et al. MR thermometry‐based feedback control of laser interstitial thermal therapy at 980 nm , 2004, Lasers in surgery and medicine.
[57] Harry J de Koning,et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.
[58] P. Walsh,et al. Dr. Patrick Walsh's Guide to Surviving Prostate Cancer , 2001 .
[59] K. Shinohara,et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. , 2001, Urology.
[60] K. Kuroda,et al. A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.
[61] Boris Rubinsky,et al. Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.
[62] D. Margolis,et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.
[63] Mark Emberton,et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.
[64] S. Berndt,et al. Letters to the Editor/Errata Re: Complications after Prostate Biopsy: Data from SEER-Medicare , 2012 .
[65] M. Porena,et al. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: Past, present, and future , 2010, Indian journal of urology : IJU : journal of the Urological Society of India.